Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioNTech SE BNTX

Healthcare Biotechnology
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BNTX)

BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024

GlobeNewswire 3 days ago

Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer

GlobeNewswire April 7, 2024

BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

GlobeNewswire March 20, 2024

BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer

GlobeNewswire March 20, 2024

BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile March 14, 2024

BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile March 13, 2024

Levi & Korsinsky Reminds BioNTech Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTX

Accesswire March 12, 2024

BNTX DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

PR Newswire March 12, 2024

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioNTech

Newsfile March 12, 2024
View More News ››

Opinion & Analysis (NDAQ:BNTX)

CureVac, BioNTech, Valeo Pharma: Where is there still potential?

Nico Popp October 16, 2020

BioNTech, Bayer, Valeo Pharma: Share price jump ahead of quarterly results

Stockhouse Editorial September 29, 2020

BioNTech, CureVac, or Valeo Pharma: who brings the highest return to shareholders?

Stockhouse Editorial September 23, 2020

BioNTech, CureVac, EXMceuticals - reaching their goal with government support

Stockhouse Editorial September 18, 2020

BioNTech, CureVac, Valeo Pharma - COVID-19 wakes up the industry

Stockhouse Editorial September 1, 2020

BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

Stockhouse Editorial July 29, 2020
View More Opinion ››

Bullboard Posts (NDAQ:BNTX)

Catastrophic Contagion 2025 - Mark the Date, and Be Ready!

if its what Bill Gates is into., podcast..  
petrojell - December 14, 2022

BioNTech Sees Vaccine Sales Push Q1 Revenues To €6.4 Billion

While many may view the pandemic as being over, the financial results of BioNTech  continue to say otherwise. The company...
AwareInvestor - May 9, 2022

BNTX to 500$? MUST video before it too late!

We don't make guesses but fact-based analysis. Check out and decide for yourself. Thank you:) https://www.youtube.com/watch?v...
latenightstocks - May 19, 2021

Biotech Top 5

What are your Top 5 Biotechs? 1. BioNTech 2. Bionano 3. Jaguar Health 4. Ocugen 5...perhaps the best one... WPD Pharmaceuticals (!?!)
Blocky - January 17, 2021

Bonvoyage12.....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on...
Mil_Man54 - December 26, 2020

Can the President Overrule the FDA on Vaccines?

An approval cycle that typically takes years is being expedited. In the case of the 2020 pandemic, the FDA  has shortened standard...
schoolofrock - October 7, 2020
View more Bullboard ››

Equity Metals Corp

Equity Metals Corp

Equity Metals Corporation is a Canada-based mineral exploration company. The Company owns 100% interest, with no underlying ...
View More »